NanoSteel
Founded Year
2002Stage
Unattributed - II | AliveTotal Raised
$91.89MLast Raised
$4.07M | 3 yrs agoMissing: NanoSteel's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: NanoSteel's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing NanoSteel
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
NanoSteel is included in 1 Expert Collection, including Advanced Materials.
Advanced Materials
1,282 items
Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.
NanoSteel Patents
NanoSteel has filed 57 patents.
The 3 most popular patent topics include:
- Metalworking
- Steels
- Metallurgy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/3/2016 | 4/18/2023 | Metallurgy, Metalworking, Metal heat treatments, Ceramic materials, Steels | Grant |
Application Date | 2/3/2016 |
|---|---|
Grant Date | 4/18/2023 |
Title | |
Related Topics | Metallurgy, Metalworking, Metal heat treatments, Ceramic materials, Steels |
Status | Grant |
Latest NanoSteel News
Mar 12, 2021
U.S. Steel announced it acquired steel sheet patents from The NanoSteel Company, Inc. Stuart Burns broke down the challenge ahead for Sanjeev Gupta’s GFG Alliance amid the collapse of its top financial backer. Earlier this week, MetalMiner completed the March update to the Annual Outlook for this year. Sohrab Darabshaw on ArcelorMittal’s plans to build a steel plant in India. Speaking of ArcelorMittal, the steelmaker sold most of its US assets to Cleveland-Cliffs — contributor Christopher Rivituso delved into ArcelorMittal’s future with its remaining North American assets. Rio Tinto announced plans to build a tellurium plant at its Kennecott mine in Utah. Elsewhere, Nucor Corporation said it will invest $164 million to build a new tube mill in the Midwest. Burns broke down news of China’s latest Five-Year Plan and what it could mean for its massive steel sector. The US Court of International Trade dismissed a challenge of the US’s Section 232 tariff exclusion process. Copper fundamentals remain strong, but the copper price recently pulled back on a classic profit-taking sell-off. Circling back to ArcelorMittal, the steelmaker is asking for cash upfront in order to supply GFG Alliance, as the latter faces financial difficulties.
NanoSteel Frequently Asked Questions (FAQ)
When was NanoSteel founded?
NanoSteel was founded in 2002.
Where is NanoSteel's headquarters?
NanoSteel's headquarters is located at 272 West Exchange Street, Providence.
What is NanoSteel's latest funding round?
NanoSteel's latest funding round is Unattributed - II.
How much did NanoSteel raise?
NanoSteel raised a total of $91.89M.
Who are the investors of NanoSteel?
Investors of NanoSteel include GM Ventures, EnerTech Capital, SPDG, Lear, Horizon Technology Finance and 7 more.
Who are NanoSteel's competitors?
Competitors of NanoSteel include Tribonex and 4 more.
Compare NanoSteel to Competitors
EA Devices is developing a high-powered needle for penetrating bone, where the company believes competition is low and present biopsy approaches have known deficiencies (operator control and fatigue, and patient anxiety and pain).
TissueTech provides regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets. AmnioGraft, AmnioGuard, and PROKERA are cryopreserved amniotic membrane grafts processed using the CRYOTEK Method to ensure that the tissue is able to deliver anti-inflammatory, anti-angiogenic, anti-scarring, and wound healing actions.
Connective Orthopaedics is a medical device company focused on the repair of soft tissue injuries.
Control Medical Technology designs, develops, and markets medical devices to help physicians, nurses, technicians, and other caregivers improve patient care. Its FDA-approved ASPIRE systems are used to remove fluids, tumors, bone, bone marrow, endometrial fluids, blood clots, tissue, and other pathology, targeting unmet clinical needs in oncology, orthopedics, spine, pain management and cardiovascular medicine.
Pegasus Biologics is developing advanced bioimplants for soft tissue reinforcement for orthopedics, sports medicine, neurosurgical and spine applications
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.